Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen W Byers

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|August 17, 2011
Putative biomarkers and targets of estrogen receptor negative human breast cancerZiad J Sahab, Yan-Gao Man, Stephen W Byers, et al.
The Journal of Biological Chemistry|May 10, 2002
The role of cadherin, beta-catenin, and AP-1 in retinoid-regulated carcinoma cell differentiation and proliferationSalimuddin Shah, Michael J Pishvaian, Vijayasurian Easwaran, et al.
Journal of Biomolecular Techniques : JBT|April 2, 2011
Small molecule metabolite extraction strategy for improving LC/MS detection of cancer cell metabolomeKathryn D Sheikh, Shefali Khanna, Stephen W Byers, et al.
Plos One|July 17, 2008
Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cellsYoshimi Endo, Kamla Deonauth, Priya Prahalad, et al.
Journal of Biomedicine & Biotechnology|October 7, 2011
Novel stromal biomarkers in human breast cancer tissues provide evidence for the more malignant phenotype of estrogen receptor-negative tumorsZahraa I Khamis, Ziad J Sahab, Stephen W Byers, et al.
Journal of Cancer|September 16, 2010
Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26Ziad J Sahab, Michael D Hall, Lihua Zhang, et al.
BMC Bioinformatics|May 7, 2016
DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposingNaiem T Issa, Jordan Kruger, Henri Wathieu, et al.
Biochemical and Biophysical Research Communications|July 27, 2010
The balance of TCF7L2 variants with differential activities in Wnt-signaling is regulated by lithium in a GSK3beta-independent mannerIan Struewing, Tania Boyechko, Corey Barnett, et al.
Inflammatory Bowel Diseases|April 11, 2012
Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseasesPeter M Clark, Noor Dawany, William Dampier, et al.
ACS Omega|June 22, 2026
Deciphering O‑GlcNAc-Dependent Signaling Via Integrated Proteomics and PhosphoproteomicsCi Wu, Chunyan Hou, Xinyue Wang, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|August 17, 2011
Putative biomarkers and targets of estrogen receptor negative human breast cancerZiad J Sahab, Yan-Gao Man, Stephen W Byers, et al.
The Journal of Biological Chemistry|May 10, 2002
The role of cadherin, beta-catenin, and AP-1 in retinoid-regulated carcinoma cell differentiation and proliferationSalimuddin Shah, Michael J Pishvaian, Vijayasurian Easwaran, et al.
Journal of Biomolecular Techniques : JBT|April 2, 2011
Small molecule metabolite extraction strategy for improving LC/MS detection of cancer cell metabolomeKathryn D Sheikh, Shefali Khanna, Stephen W Byers, et al.
Plos One|July 17, 2008
Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cellsYoshimi Endo, Kamla Deonauth, Priya Prahalad, et al.
Journal of Biomedicine & Biotechnology|October 7, 2011
Novel stromal biomarkers in human breast cancer tissues provide evidence for the more malignant phenotype of estrogen receptor-negative tumorsZahraa I Khamis, Ziad J Sahab, Stephen W Byers, et al.
Journal of Cancer|September 16, 2010
Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26Ziad J Sahab, Michael D Hall, Lihua Zhang, et al.
BMC Bioinformatics|May 7, 2016
DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposingNaiem T Issa, Jordan Kruger, Henri Wathieu, et al.
Biochemical and Biophysical Research Communications|July 27, 2010
The balance of TCF7L2 variants with differential activities in Wnt-signaling is regulated by lithium in a GSK3beta-independent mannerIan Struewing, Tania Boyechko, Corey Barnett, et al.
Inflammatory Bowel Diseases|April 11, 2012
Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseasesPeter M Clark, Noor Dawany, William Dampier, et al.
ACS Omega|June 22, 2026
Deciphering O‑GlcNAc-Dependent Signaling Via Integrated Proteomics and PhosphoproteomicsCi Wu, Chunyan Hou, Xinyue Wang, et al.
Pageof 6